INSPIRE MEDICAL SYSTEMS INC (INSP) Stock Fundamental Analysis
USA - NYSE:INSP - US4577301090 - Common Stock
82.015 USD
+8.31 (+11.27%)
INSP gets a fundamental rating of 6 out of 10. The analysis compared the fundamentals against 189 industry peers in the Health Care Equipment & Supplies industry. INSP is in great health and has no worries on liquidiy or solvency at all, but the profibility rating is only average. INSP is growing strongly while it is still valued neutral. This is a good combination! This makes INSP very considerable for growth investing!
1. Profitability
1.1 Basic Checks
In the past year INSP was profitable.
In the past year INSP had a positive cash flow from operations.
In the past 5 years INSP reported 4 times negative net income.
The reported operating cash flow has been mixed in the past 5 years: INSP reported negative operating cash flow in multiple years.
1.2 Ratios
The Return On Assets of INSP (6.62%) is better than 86.77% of its industry peers.
With an excellent Return On Equity value of 7.84%, INSP belongs to the best of the industry, outperforming 81.48% of the companies in the same industry.
With a decent Return On Invested Capital value of 5.35%, INSP is doing good in the industry, outperforming 77.78% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 6.62% | ||
| ROE | 7.84% | ||
| ROIC | 5.35% |
ROA(3y)-1.48%
ROA(5y)-7.81%
ROE(3y)-1.66%
ROE(5y)-9.65%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
Looking at the Profit Margin, with a value of 6.17%, INSP is in the better half of the industry, outperforming 77.25% of the companies in the same industry.
With a decent Operating Margin value of 4.81%, INSP is doing good in the industry, outperforming 69.31% of the companies in the same industry.
INSP has a Gross Margin of 84.47%. This is amongst the best in the industry. INSP outperforms 94.18% of its industry peers.
INSP's Gross Margin has been stable in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 4.81% | ||
| PM (TTM) | 6.17% | ||
| GM | 84.47% |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.41%
GM growth 5Y0.33%
2. Health
2.1 Basic Checks
With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), INSP is destroying value.
INSP has more shares outstanding than it did 1 year ago.
INSP has more shares outstanding than it did 5 years ago.
INSP has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
2.2 Solvency
An Altman-Z score of 11.97 indicates that INSP is not in any danger for bankruptcy at the moment.
INSP's Altman-Z score of 11.97 is amongst the best of the industry. INSP outperforms 91.01% of its industry peers.
There is no outstanding debt for INSP. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | 0 | ||
| Altman-Z | 11.97 |
ROIC/WACC0.61
WACC8.75%
2.3 Liquidity
INSP has a Current Ratio of 6.14. This indicates that INSP is financially healthy and has no problem in meeting its short term obligations.
INSP has a Current ratio of 6.14. This is amongst the best in the industry. INSP outperforms 83.07% of its industry peers.
A Quick Ratio of 4.84 indicates that INSP has no problem at all paying its short term obligations.
INSP has a Quick ratio of 4.84. This is amongst the best in the industry. INSP outperforms 83.60% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 6.14 | ||
| Quick Ratio | 4.84 |
3. Growth
3.1 Past
The Earnings Per Share has grown by an impressive 94.39% over the past year.
Looking at the last year, INSP shows a very strong growth in Revenue. The Revenue has grown by 28.49%.
The Revenue has been growing by 57.78% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)94.39%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-36.67%
Revenue 1Y (TTM)28.49%
Revenue growth 3Y50.95%
Revenue growth 5Y57.78%
Sales Q2Q%10.49%
3.2 Future
The Earnings Per Share is expected to grow by 26.47% on average over the next years. This is a very strong growth
INSP is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 14.74% yearly.
EPS Next Y-70.2%
EPS Next 2Y-3.49%
EPS Next 3Y16.27%
EPS Next 5Y26.47%
Revenue Next Year13.03%
Revenue Next 2Y13.73%
Revenue Next 3Y13.96%
Revenue Next 5Y14.74%
3.3 Evolution
The estimated forward Revenue growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
4. Valuation
4.1 Price/Earnings Ratio
INSP is valuated quite expensively with a Price/Earnings ratio of 39.43.
70.37% of the companies in the same industry are more expensive than INSP, based on the Price/Earnings ratio.
The average S&P500 Price/Earnings ratio is at 26.51. INSP is valued slightly more expensive when compared to this.
The Price/Forward Earnings ratio is 50.90, which means the current valuation is very expensive for INSP.
Based on the Price/Forward Earnings ratio, INSP is valued a bit cheaper than the industry average as 69.31% of the companies are valued more expensively.
INSP's Price/Forward Earnings ratio indicates a rather expensive valuation when compared to the S&P500 average which is at 22.53.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 39.43 | ||
| Fwd PE | 50.9 |
4.2 Price Multiples
Based on the Enterprise Value to EBITDA ratio, INSP is valued a bit cheaper than the industry average as 70.90% of the companies are valued more expensively.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of INSP indicates a rather cheap valuation: INSP is cheaper than 81.48% of the companies listed in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 28.53 | ||
| EV/EBITDA | 32.28 |
4.3 Compensation for Growth
A more expensive valuation may be justified as INSP's earnings are expected to grow with 16.27% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-3.49%
EPS Next 3Y16.27%
5. Dividend
5.1 Amount
INSP does not give a dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
NYSE:INSP (11/4/2025, 9:48:05 AM)
82.015
+8.31 (+11.27%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)
Earnings (Next)
Inst Owners109.56%
Inst Owner Change-2.18%
Ins Owners0.82%
Ins Owner Change0.18%
Market Cap2.43B
Revenue(TTM)802.80M
Net Income(TTM)53.12M
Analysts73.85
Price Target127.13 (55.01%)
Short Float %10.54%
Short Ratio2.84
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)127.01%
Min EPS beat(2)114.53%
Max EPS beat(2)139.49%
EPS beat(4)4
Avg EPS beat(4)247.35%
Min EPS beat(4)54.07%
Max EPS beat(4)681.29%
EPS beat(8)8
Avg EPS beat(8)257.08%
EPS beat(12)12
Avg EPS beat(12)187.32%
EPS beat(16)16
Avg EPS beat(16)150.49%
Revenue beat(2)1
Avg Revenue beat(2)0.22%
Min Revenue beat(2)-0.69%
Max Revenue beat(2)1.13%
Revenue beat(4)2
Avg Revenue beat(4)0.1%
Min Revenue beat(4)-0.84%
Max Revenue beat(4)1.13%
Revenue beat(8)4
Avg Revenue beat(8)-0.06%
Revenue beat(12)8
Avg Revenue beat(12)2.61%
Revenue beat(16)12
Avg Revenue beat(16)3.81%
PT rev (1m)-14.21%
PT rev (3m)-42.18%
EPS NQ rev (1m)4.35%
EPS NQ rev (3m)-134.09%
EPS NY rev (1m)1.51%
EPS NY rev (3m)-77.98%
Revenue NQ rev (1m)0.01%
Revenue NQ rev (3m)-8.27%
Revenue NY rev (1m)-0.02%
Revenue NY rev (3m)-4.79%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 39.43 | ||
| Fwd PE | 50.9 | ||
| P/S | 2.82 | ||
| P/FCF | 28.53 | ||
| P/OCF | 20.65 | ||
| P/B | 3.58 | ||
| P/tB | 3.58 | ||
| EV/EBITDA | 32.28 |
EPS(TTM)2.08
EY2.54%
EPS(NY)1.61
Fwd EY1.96%
FCF(TTM)2.87
FCFY3.51%
OCF(TTM)3.97
OCFY4.84%
SpS29.13
BVpS22.92
TBVpS22.92
PEG (NY)N/A
PEG (5Y)N/A
Graham Number32.75
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 6.62% | ||
| ROE | 7.84% | ||
| ROCE | 5.84% | ||
| ROIC | 5.35% | ||
| ROICexc | 9.29% | ||
| ROICexgc | 9.29% | ||
| OM | 4.81% | ||
| PM (TTM) | 6.17% | ||
| GM | 84.47% | ||
| FCFM | 9.87% |
ROA(3y)-1.48%
ROA(5y)-7.81%
ROE(3y)-1.66%
ROE(5y)-9.65%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.41%
GM growth 5Y0.33%
F-Score7
Asset Turnover1.07
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | 0 | ||
| Debt/EBITDA | 0 | ||
| Cap/Depr | 300.74% | ||
| Cap/Sales | 3.77% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 225.05% | ||
| Profit Quality | 160.03% | ||
| Current Ratio | 6.14 | ||
| Quick Ratio | 4.84 | ||
| Altman-Z | 11.97 |
F-Score7
WACC8.75%
ROIC/WACC0.61
Cap/Depr(3y)638.93%
Cap/Depr(5y)518.49%
Cap/Sales(3y)3.63%
Cap/Sales(5y)3%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)94.39%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-36.67%
EPS Next Y-70.2%
EPS Next 2Y-3.49%
EPS Next 3Y16.27%
EPS Next 5Y26.47%
Revenue 1Y (TTM)28.49%
Revenue growth 3Y50.95%
Revenue growth 5Y57.78%
Sales Q2Q%10.49%
Revenue Next Year13.03%
Revenue Next 2Y13.73%
Revenue Next 3Y13.96%
Revenue Next 5Y14.74%
EBIT growth 1Y389.07%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year586.15%
EBIT Next 3Y128.27%
EBIT Next 5Y79.05%
FCF growth 1Y348.82%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y245.22%
OCF growth 3YN/A
OCF growth 5YN/A
INSPIRE MEDICAL SYSTEMS INC / INSP FAQ
Can you provide the ChartMill fundamental rating for INSPIRE MEDICAL SYSTEMS INC?
ChartMill assigns a fundamental rating of 6 / 10 to INSP.
What is the valuation status of INSPIRE MEDICAL SYSTEMS INC (INSP) stock?
ChartMill assigns a valuation rating of 4 / 10 to INSPIRE MEDICAL SYSTEMS INC (INSP). This can be considered as Fairly Valued.
Can you provide the profitability details for INSPIRE MEDICAL SYSTEMS INC?
INSPIRE MEDICAL SYSTEMS INC (INSP) has a profitability rating of 5 / 10.
Can you provide the financial health for INSP stock?
The financial health rating of INSPIRE MEDICAL SYSTEMS INC (INSP) is 8 / 10.
What is the expected EPS growth for INSPIRE MEDICAL SYSTEMS INC (INSP) stock?
The Earnings per Share (EPS) of INSPIRE MEDICAL SYSTEMS INC (INSP) is expected to decline by -70.2% in the next year.